期刊文献+

盐酸特比萘芬溶液的透皮吸收 被引量:2

Transdermic absorption of terbinafine liquor
下载PDF
导出
摘要 目的观察1%盐酸特比萘芬溶液经皮肤给药后药物在体内的吸收性和蓄积性。方法6只新西兰大白兔,每兔皮肤单次涂药液8ml·d-1,收集24h内药时血样。随后连续涂药液7d,收集每日峰、谷浓度血样,用高效液相色谱(HPLC)测定兔血清特比萘芬血药浓度。结果药物透皮吸收3hCmax8.3±3.7μg·L-1,随着血药浓度下降维持一个较低水平。连续7d,药峰浓度在d3达10.5±3.0μg·L-1,随后数日峰浓度维持于一平台水平,谷浓度无明显变化。结论1%盐酸特比萘芬溶液没有体内累积现象。 AIM: To investigate the transdermic absorption and accumulation in vivo after dermic administration of 1% liquor of terbinafini hydrochloridum. METHODS: 6 New Zealand white rabbits were used in this experiment. 8 ml of the liquor was coated on the back skin of each rabbit. Blood were collected at 0.5 , 1, 1.5 , 2, 3, 4, 6, 8, 12 and 24 h before and after single administration. Blood were collected at peak and trough points everyday in the continuous multiple administrations which was once per day for 7 days. The serum concentrations of terbinafine were determined by high performance liquid chromatography. RESULTS: The peak concentration of terbinafine arrived at 2-3 h and C max was 8.6 ± 1.8 μg·L -1 . The peak concentration of terbinafine increased gradually after continuous multiple administrations, but there only increased 1.33 times in fourth day, and more than that in first day. In following three days, the peak concentrations tend to steady state. There was no significantly increase or decrease in trough concentration. CONCLUSION: There is no accumulation in vivo after dermic administration of 1% liquor of terbinafini hydrochloridum.
出处 《中国临床药理学与治疗学》 CAS CSCD 2004年第10期1172-1174,共3页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 高效液相色谱法 特比萘芬 血药浓度 皮吸收 蓄积性 high performance liquid chromatography terbinafine serum concentration transdermic absorption cumulation
  • 相关文献

参考文献2

  • 1[1]Dykes PJ, Thomas R, Lever L, Marks R. Pharmacokinetics of topically applied terbinafine: results from studies in healthy valunteer subjects and patients with pityriasis versicolor[ J]. J Dermatol Treat, 1990; 1(2): 19 - 21
  • 2[2]Balfour JA, Faulds D. Terbinafine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses[J]. Drugs, 1992; 43(2): 259 - 84

同被引文献12

  • 1ROBERTS D T. Oral terbinafine(lamisil) in the treatment of fungal infections of the skin [J]. Dermatology, 1997, 194(1): 39-37.
  • 2LBWOHL M. The role of salicylic acid in the treatment of psoriasis [J]. lnt J Dermatol, 1999, 8(1): 16-24.
  • 3DENOUEL J. Determination of terbinafine and its desmethyl metabolite in human plasma by high-performance liquid chromatography [J]. J Chromatogr B, 1995, 663(2): 353-361.
  • 4JENSEN J C. Pharmacokinetics of lamisil in human [J]. J Dermato Treat, 1990, 14(2): 1-15.
  • 5JENSEN J C. Clinical pharmacokinetics of lamisil in humans [J]. J Dermatol Treat, 1990, 14(2):15-]8.
  • 6RUI Y C. Modem Pharmacology (现代药物学) [M]. Beijing: People's Military Surgeon Publishing House, 1999: 430.
  • 7李军,王建筑,张鉴,卜秀玲,彭向前,徐济萍.RP-HPLC法测定正常人血浆中阿司匹林酯酶活性[J].药物分析杂志,2007,27(9):1382-1385. 被引量:13
  • 8Gupta AK, Einarson TR, Summerbell RC, et al. An overview of topical antifungal therapy in dermatomycoses. A North American perspective [J]. Drugs, 1998, 55(5):645-674.
  • 9Harrison S M ,Barry B W, Dugard P H. Effects of Freezing on Human Skin Perme-ability[J]. J Pharm Pharmacol, 1984, 36(4):261-262.
  • 10陈润滋,袁成.特比萘芬在健康志愿者指趾甲中的分布[J].中国临床药学杂志,1999,8(2):89-91. 被引量:4

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部